XML 57 R52.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Compensation Expense The following table summarizes stock option compensation expense for the years ended December 31, 2019, 2018, and 2017:

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Total share-based compensation (benefit) - stock options

 

$

(106

)

 

$

458

 

 

$

1,294

 

Income tax benefit (expense)

 

 

(29

)

 

 

127

 

 

 

521

 

Unrecognized compensation expense - stock options

 

 

7

 

 

 

146

 

 

 

729

 

Weighted-average amortization period remaining

 

0.3 years

 

 

1.1 years

 

 

1.2 years

 

 

 

Restricted Shares  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Stock Compensation Expense

The following table summarizes restricted stock compensation expense for the years ended:

 

 

Years Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Total share-based compensation - restricted stock

 

$

1,965

 

 

$

958

 

 

$

203

 

Income tax benefit

 

 

547

 

 

 

267

 

 

 

83

 

Unrecognized compensation expense - restricted stock

 

 

4,616

 

 

 

3,167

 

 

 

1,227

 

Weighted-average amortization period remaining

 

2.6 years

 

 

2.9 years

 

 

2.8 years

 

Omnibus Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Changes in Restricted Shares

The following table discloses the changes in restricted shares for the year ended December 31, 2019:

 

 

 

Omnibus Plan

 

 

 

Number of Shares

 

 

Weighted Average Grant Date Fair Value

 

Beginning balance, January 1, 2019

 

 

196,480

 

 

$

21.66

 

Granted

 

 

210,622

 

 

 

18.68

 

Vested

 

 

(48,491

)

 

 

21.62

 

Forfeited

 

 

(29,958

)

 

 

19.73

 

Ending balance outstanding at December 31, 2019

 

 

328,653

 

 

$

19.94

 

BYB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options and the weighted average exercise prices, in actual dollars, for the year ended December 31, 2019:

 

 

 

BYB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2019

 

 

1,598,872

 

 

$

11.84

 

 

$

7,713

 

 

 

6.6

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(127,997

)

 

$

14.71

 

 

$

521

 

 

 

 

 

Forfeited

 

 

(60,800

)

 

$

16.25

 

 

 

 

 

 

 

 

 

Ending balance outstanding at December 31, 2019

 

 

1,410,075

 

 

$

11.38

 

 

$

11,542

 

 

 

5.4

 

Exercisable at December 31, 2019

 

 

1,390,075

 

 

$

11.31

 

 

$

11,475

 

 

 

5.4

 

FEB Plan  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Activity in shares Subjected to Options and Weighted Average Exercise Prices

The following table discloses the activity in shares subject to options under the FEB Plan and the weighted average exercise prices, in actual dollars, for the year ended December 31, 2019:

 

 

 

FEB Plan

 

 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Intrinsic Value

 

 

Weighted Average Remaining Contractual Term (in Years)

 

Beginning balance, January 1, 2019

 

 

624,383

 

 

$

11.31

 

 

$

3,339

 

 

 

5.2

 

Granted

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expired

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercised

 

 

(113,214

)

 

 

11.17

 

 

$

909

 

 

 

 

 

Forfeited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Ending balance outstanding at December 31, 2019

 

 

511,169

 

 

$

11.35

 

 

$

4,204

 

 

 

4.4

 

Exercisable at December 31, 2019

 

 

511,169

 

 

$

11.35

 

 

$

4,204

 

 

 

4.4